Store besparelser
Hurtig levering
Gemte
Log ind
0
Kurv
Bøger
Bestsellers
Kommer snart
Nyheder
Spil og hobby
Kurv
  1. Bog
  2. Farmakologi
  3. Psykofarmakologi

From Breakthrough to Blockbuster

- The Business of Biotechnology
Af: Lisa N. Drakeman, Donald L. Drakeman, Nektarios Oraiopoulos Engelsk Hardback

From Breakthrough to Blockbuster

- The Business of Biotechnology
Af: Lisa N. Drakeman, Donald L. Drakeman, Nektarios Oraiopoulos Engelsk Hardback
Tjek vores konkurrenters priser
Financial Times Business Top Title March 2022How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world''s most breathtakingly expensive and highly regulated industries?Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
Vis mere
Tjek vores konkurrenters priser
Normalpris
kr 316
Fragt: 39 kr
6 - 8 hverdage
20 kr
Pakkegebyr
God 4 anmeldelser på
Tjek vores konkurrenters priser
Financial Times Business Top Title March 2022How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world''s most breathtakingly expensive and highly regulated industries?Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
Vis mere
Se mere i:
Produktdetaljer
Sprog: Engelsk
Sider: 240
ISBN-13: 9780195084009
Indbinding: Hardback
Udgave:
ISBN-10: 0195084004
Kategori: Psykofarmakologi
Udg. Dato: 7 jul 2022
Længde: 24mm
Bredde: 241mm
Højde: 166mm
Forlag: Oxford University Press Inc
Oplagsdato: 7 jul 2022
Forfatter(e): Lisa N. Drakeman, Donald L. Drakeman, Nektarios Oraiopoulos
Forfatter(e) Lisa N. Drakeman, Donald L. Drakeman, Nektarios Oraiopoulos

Kategori Psykofarmakologi

ISBN-13 9780195084009

Sprog Engelsk

Indbinding Hardback

Sider 240

Udgave

Længde 24mm

Bredde 241mm

Højde 166mm

Udg. Dato 7 jul 2022

Oplagsdato 7 jul 2022

Forlag Oxford University Press Inc